Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 751–765 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-1068
TSC1 & TSC2 Gene Analysis Test

This test identifies pathogenic variants in the TSC1 and TSC2 genes, confirming a diagnosis of Tuberous Sclerosis Complex.

Peripheral blood, amniotic fluid, chorionic villi 4–6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in TSC1 gene", "Pathogenic variants in TSC2 gene"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of Tuberous Sclerosis Complex", "Family history of TSC", "Prenatal diagnosis", "Genetic counseling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 85444-9 ICD-10: Q85.1
Clinical summary
This test identifies pathogenic variants in the TSC1 and TSC2 genes, confirming a diagnosis of Tuberous Sclerosis Complex.
TEST-3703
TSHR Gene Mutation Analysis for Congenital Nongoitrous Hypothyroidism Typeβ€―1 (NGS) Test

This test identifies pathogenic variants in the TSHR gene associated with congenital nongoitrous hypothyroidism type 1.

Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA 21–28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in TSHR gene coding exons and splice junctions"]
Parameters
[]
Preparation
["No specific patient preparation required"]
Indications
["Diagnosis of congenital nongoitrous hypothyroidism type 1", "Family risk assessment", "Reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21647-7 ICD-10: E03.1
Clinical summary
This test identifies pathogenic variants in the TSHR gene associated with congenital nongoitrous hypothyroidism type 1.
TEST-585
TTV RNA Detection Qualitative Test

This test detects the presence of Torque Teno virus RNA in a patient sample, indicating an active infection.

Serum, Plasma, Whole Blood, Saliva, Semen, Stool 1 Week 950.00 AED
View
View test specifications and preparation
What it measures
["Torque Teno virus (TTV) RNA", "Active viral replication"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Immune surveillance in chronic fatigue syndromes", "Monitoring immunocompromised patients", "Investigation of potential transfusion-transmitted infections"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88510-9 ICD-10: B34.8
Clinical summary
This test detects the presence of Torque Teno virus RNA in a patient sample, indicating an active infection.
TEST-685
UAE Trusted Parainfluenza 1,2,3,4 Multiplex Detection & Differentiation Quantitative Test

This diagnostic test evaluates for the presence and quantity of Parainfluenza virus types 1, 2, 3, and 4 in a respiratory sample.

Respiratory Specimen (Nasopharyngeal Swab) 36 to 48 Hours 1,400.00 AED
View
View test specifications and preparation
What it measures
["Parainfluenza virus type 1 RNA", "Parainfluenza virus type 2 RNA", "Parainfluenza virus type 3 RNA", "Parainfluenza virus type 4 RNA", "Viral Load Quantification"]
Parameters
[]
Preparation
["No special preparation is required."]
Indications
["Diagnosis of Parainfluenza virus infection", "Differentiation between Parainfluenza virus subtypes", "Viral load assessment in immunocompromised patients", "Outbreak surveillance", "Guiding antiviral therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 104168-5 ICD-10: B97.4
Clinical summary
This diagnostic test evaluates for the presence and quantity of Parainfluenza virus types 1, 2, 3, and 4 in a respiratory sample.
TEST-3812
UBE3A Gene Angelman Syndrome Genetic Test

This test identifies pathogenic variants in the UBE3A gene associated with Angelman syndrome.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["UBE3A gene variants", "Single-nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy-number variations (CNVs)", "Uniparental disomy (UPD)"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of Angelman syndrome", "Family history of Angelman syndrome", "Neurological work-up for developmental delay/intellectual disability"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82907-1 ICD-10: Q93.5
Clinical summary
This test identifies pathogenic variants in the UBE3A gene associated with Angelman syndrome.
TEST-5431
UCHL1 Gene PARK5 Parkinson's Disease Genetic Test

This test evaluates the UCHL1 gene for pathogenic variants associated with autosomal dominant Parkinson's disease.

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["UCHL1 gene sequence", "Pathogenic variants in coding regions and splice junctions"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Individuals with a family history of early-onset Parkinson's disease", "Confirmed UCHL1 mutation in a first-degree relative", "Risk assessment for autosomal dominant Parkinson's disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93196-7 ICD-10: G20
Clinical summary
This test evaluates the UCHL1 gene for pathogenic variants associated with autosomal dominant Parkinson's disease.
TEST-124
Ultra‑Low Input Eukaryotic mRNA Sequencing (Reference‑Based Analysis) Test

This test evaluates the complete set of messenger RNA transcripts from extremely limited biological samples to measure gene expression levels.

Whole Blood (Specialized RNA Preservative Tube) or Fresh/Frozen Tissue 8 weeks 3,500.00 AED
View
View test specifications and preparation
What it measures
["Gene expression levels", "Novel isoforms", "Splice variants", "Transcriptome coverage"]
Parameters
[]
Preparation
[]
Indications
["Oncology (rare cell transcriptomics)", "Rheumatology", "Biomarker discovery", "Analysis of precious or scarce specimens (e.g., tumor biopsies, circulating tumor cells, sorted cell populations)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103164-6 ICD-10: Z13.79, Z14.8, R89.8
Clinical summary
This test evaluates the complete set of messenger RNA transcripts from extremely limited biological samples to measure gene expression levels.
TEST-3801
UMOD Gene Glomerulocystic Kidney Disease with Hyperuricemia and Isosthenuria Genetic Test

This test identifies pathogenic variants in the UMOD gene associated with a specific type of inherited kidney disease.

Peripheral whole blood (3–5 mL in EDTA tube) or extracted DNA (2 Β΅g minimum) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the UMOD gene", "Copy number variants (CNVs) in the UMOD gene"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your physician"]
Indications
["Suspected UMOD-related glomerulocystic kidney disease", "Family history of UMOD-related kidney disease", "Need for genetic counselling and cascade testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92853-9 ICD-10: Q61.8, E79.0
Clinical summary
This test identifies pathogenic variants in the UMOD gene associated with a specific type of inherited kidney disease.
TEST-3556
UNC119 Gene Cone-Rod Dystrophy Genetic Test

This test evaluates the UNC119 gene for pathogenic variants associated with autosomal dominant cone-rod dystrophy.

Whole Blood, DNA swab, or one-drop dried blood FTA card 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["UNC119 gene sequence", "Pathogenic variants in UNC119"]
Parameters
[]
Preparation
["Maintain usual diet and medications", "Attend a genetic counseling session to document a three-generation family pedigree"]
Indications
["Suspected cone-rod dystrophy", "Family history of cone-rod dystrophy", "Need for genetic confirmation for clinical management or family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101190-8 ICD-10: H35.53, H35.5, Z14.0
Clinical summary
This test evaluates the UNC119 gene for pathogenic variants associated with autosomal dominant cone-rod dystrophy.
TEST-3365
Varicella Zoster Virus (VZV) Qualitative PCR Test

This diagnostic test evaluates the presence of varicella-zoster virus DNA in patient samples.

Whole blood (EDTA) or Cerebrospinal Fluid (CSF) 2 business days (samples received Mon/Thu before 11 AM; reports issued Wed/Sat) 650.00 AED
View
View test specifications and preparation
What it measures
["Varicella Zoster Virus DNA"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}, {"name": "Diagnostic Specificity", "reference_range": "99.9%"}]
Preparation
["No fasting required", "Inform healthcare provider about all medications"]
Indications
["Suspected active chickenpox", "Suspected active shingles", "Diagnosis of VZV encephalitis or meningitis", "Confirmation of VZV in immunocompromised patients"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3399-1 ICD-10: B01.9, B02.9
Clinical summary
This diagnostic test evaluates the presence of varicella-zoster virus DNA in patient samples.
TEST-1064
VNTR Chimerism Analysis (Post-BMT) Test

This diagnostic test evaluates the proportion of donor versus recipient DNA in peripheral blood post-bone marrow transplant.

Whole Blood (Peripheral) 3–4 working days (express option available) 1,000.00 AED
View
View test specifications and preparation
What it measures
["Donor DNA fraction", "Recipient DNA fraction", "Chimerism level"]
Parameters
[]
Preparation
["Do not discontinue prescribed immunosuppressive, corticosteroid, or antimicrobial therapy unless directed by your transplant physician."]
Indications
["Post-bone marrow transplant monitoring", "Early detection of graft failure", "Molecular relapse assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86214-7 ICD-10: Z94.81
Clinical summary
This diagnostic test evaluates the proportion of donor versus recipient DNA in peripheral blood post-bone marrow transplant.
TEST-1059
VNTR Chimerism Study (Pre-BMT) Test

This test establishes a baseline genetic fingerprint using VNTR analysis before bone marrow transplantation to monitor donor cell engraftment post-transplant.

Peripheral whole blood (recipient and donor) 3–4 business days 1,000.00 AED
View
View test specifications and preparation
What it measures
["Recipient's unique DNA fingerprint", "Donor cell engraftment post-transplant"]
Parameters
[]
Preparation
[]
Indications
["Pre-bone marrow transplantation evaluation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81200-6 ICD-10: Z01.818
Clinical summary
This test establishes a baseline genetic fingerprint using VNTR analysis before bone marrow transplantation to monitor donor cell engraftment post-transplant.
TEST-5419
VPS35 Gene (PARK17) Parkinson's Disease Genetic Test

This test identifies pathogenic mutations in the VPS35 gene, which are associated with autosomal dominant Parkinson's disease.

Whole Blood, Extracted DNA, or One Drop Blood on FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the VPS35 gene"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of autosomal dominant Parkinson's disease", "Family risk assessment", "Guiding personalized treatment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93852-2 ICD-10: G20
Clinical summary
This test identifies pathogenic mutations in the VPS35 gene, which are associated with autosomal dominant Parkinson's disease.
TEST-1060
Warfarin Therapeutic Response Predictive Assay (VKORC1 & CYP2C9) Test

This test evaluates genetic variations in the VKORC1 and CYP2C9 genes that influence warfarin metabolism and sensitivity.

Peripheral Whole Blood (EDTA) 3–4 Working Days 800.00 AED
View
View test specifications and preparation
What it measures
["VKORC1 gene polymorphisms", "CYP2C9 gene polymorphisms", "Warfarin metabolism phenotype"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist of anticoagulant medications"]
Indications
["Patients starting warfarin therapy", "Patients experiencing difficulty achieving stable INR on warfarin", "Patients with suspected warfarin sensitivity or resistance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93025-6 ICD-10: Z13.89
Clinical summary
This test evaluates genetic variations in the VKORC1 and CYP2C9 genes that influence warfarin metabolism and sensitivity.
TEST-556
West Nile Virus RNA Qualitative PCR Test

This test detects the genetic material (RNA) of the West Nile virus in patient samples.

Serum, Plasma, Whole Blood, Cerebrospinal Fluid (CSF) 3 working days (email); urgent phone result in 24 hours 850.00 AED
View
View test specifications and preparation
What it measures
["West Nile Virus RNA"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Suspected acute West Nile virus infection", "Neurological symptoms following potential mosquito exposure", "Public health surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48411-2 ICD-10: A92.3
Clinical summary
This test detects the genetic material (RNA) of the West Nile virus in patient samples.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area